SEVEN SEAS LIMITED

Active Weybridge

Manufacture of basic pharmaceutical products

0 employees website.com
Healthcare and wellbeing Manufacture of basic pharmaceutical products
S

SEVEN SEAS LIMITED

Manufacture of basic pharmaceutical products

Founded 6 Apr 1939 Active Weybridge, United Kingdom 0 employees website.com
Healthcare and wellbeing Manufacture of basic pharmaceutical products

Previous Company Names

MARFLEET REFINING COMPANY LIMITED 6 Apr 1939 — 31 Mar 1988
Accounts Submitted 12 Jan 2026 Next due 31 Mar 2027 10 months remaining
Confirmation Submitted 30 May 2026 Next due 28 May 2027 11 months remaining
Net assets £131K £953K 2025 year on year
Total assets £131K £953K 2025 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Heights Brooklands Weybridge Surrey KT13 0XP

Website

www.example.com

Full company profile for SEVEN SEAS LIMITED (00351663), an active healthcare and wellbeing company based in Weybridge, United Kingdom. Incorporated 6 Apr 1939. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type full
Next accounts 30 Jun 2026
Due by 31 Mar 2027 10 months remaining

Balance Sheet & P&L (2013–2025)

Cash in Bank

N/A

Net Assets

£131.00k

Decreased by £953.00k (-88%)

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 1 Shares £43.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Nov 20181€43.00m€43.00m

Officers

Officers

1 active 2 resigned
Status
Ewen, Andrew MccallumDirectorBritishEngland5526 Feb 2021Active

Shareholders

Shareholders (1)

Procter & Gamble Health Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

SEVEN SEAS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
1301 Hedon Road, Kingston upon Hull CITY OF KINGSTON UPON HULL
Leasehold-11 Dec 1997
1301 Hedon Road, Kingston upon Hull
Leasehold
Added 11 Dec 1997
District CITY OF KINGSTON UPON HULL

Documents

Company Filings

DateCategoryDescriptionDocument
30 May 2026Confirmation StatementConfirmation statement made on 14 May 2026 with no updates
12 Jan 2026AccountsAnnual accounts made up to 30 Jun 2025
16 Sept 2025OfficersAppointment of Mr Alessandro Catellani as director on 8 Sept 2025
15 Sept 2025OfficersTermination of Christopher John Young as director on 8 Sept 2025
17 May 2025Confirmation StatementConfirmation statement made on 14 May 2025 with no updates
30 May 2026 Confirmation Statement

Confirmation statement made on 14 May 2026 with no updates

12 Jan 2026 Accounts

Annual accounts made up to 30 Jun 2025

16 Sept 2025 Officers

Appointment of Mr Alessandro Catellani as director on 8 Sept 2025

15 Sept 2025 Officers

Termination of Christopher John Young as director on 8 Sept 2025

17 May 2025 Confirmation Statement

Confirmation statement made on 14 May 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 14 May 2026 with no updates

3 days ago on 30 May 2026

Annual accounts made up to 30 Jun 2025

4 months ago on 12 Jan 2026

Appointment of Mr Alessandro Catellani as director on 8 Sept 2025

8 months ago on 16 Sept 2025

Termination of Christopher John Young as director on 8 Sept 2025

8 months ago on 15 Sept 2025

Confirmation statement made on 14 May 2025 with no updates

1 years ago on 17 May 2025